2022-05-04T14:35:49Z
2022-05-04T14:35:49Z
2020-11-11
2022-05-04T14:35:49Z
Introduction: Amyloid beta (Aβ) pathology is an Alzheimer's disease early hallmark. Here we assess the value of longitudinal self- and informant reports of cognitive decline to predict Aβ positron emission tomography (PET) outcome in cognitively unimpaired middle-aged individuals. Methods: A total of 261 participants from the ALFA+ study underwent [18F]flutemetamol PET and Subjective Cognitive Decline Questionnaire (SCD-Q) concurrently, and 3 years before scan. We used logistic regressions to evaluate the ability of SCD-Q scores (self and informant) to predict Aβ PET visual read, and repeated analysis of variance to assess whether changes in SCD-Q scores relate to Aβ status. Results: Self-perception of decline in memory (odds ratio [OR] = 1.2), and informant perception of executive decline (OR = 1.6), increased the probability of a positive scan. Informant reports 3 years before scanning predicted Aβ PET outcome. Longitudinal increase of self-reported executive decline was predictive of Aβ in women (P = .003). Discussion: Subjective reports of cognitive decline are useful to predict Aβ and may improve recruitment strategies.
Article
Published version
English
Malaltia d'Alzheimer; Amiloïdosi; Trastorns de la cognició; Símptomes; Diagnòstic; Alzheimer's disease; Amyloidosis; Cognition disorders; Symptoms; Diagnosis
Alzheimer's Association
Reproducció del document publicat a: https://doi.org/10.1002/dad2.12127
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring (DADM) , 2020, vol. 12, num. 1
https://doi.org/10.1002/dad2.12127
info:eu-repo/grantAgreement/EC/H2020/752310/EU//BioALFA
cc-by-nc (c) Sánchez Benavides, Gonzalo et al., 2020
https://creativecommons.org/licenses/by-nc/4.0/